Rangnekar VM - Search Results

1

Differential expression levels of Par-4 in melanoma.

Lucas T, Pratscher B, Krishnan S, Fink D, Günsberg P, Wolschek M, Wacheck V, Muster T, Romirer I, Wolff K, Pehamberger H, Eichler HG, Rangnekar VM, Jansen B. Lucas T, et al. Among authors: rangnekar vm. Melanoma Res. 2001 Aug;11(4):379-83. doi: 10.1097/00008390-200108000-00008. Melanoma Res. 2001. PMID: 11479426

2

Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.

Jose A, Kulkarni P, Thilakan J, Munisamy M, Malhotra AG, Singh J, Kumar A, Rangnekar VM, Arya N, Rao M. Jose A, et al. Among authors: rangnekar vm. Mol Cancer. 2024 Mar 9;23(1):50. doi: 10.1186/s12943-023-01916-6. Mol Cancer. 2024. PMID: 38461268 Free PMC article. Review.

3

Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer.

Parida P, Lewis S, Sharan K, Kamal MV, Kumar NAN, Godkhindi VM, Varambally S, Rangnekar VM, Rao M, Damerla RR. Parida P, et al. Among authors: rangnekar vm. Cells. 2023 Oct 27;12(21):2530. doi: 10.3390/cells12212530. Cells. 2023. PMID: 37947608 Free PMC article.

4

Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.

Cook J, Krishnan S, Ananth S, Sells SF, Shi Y, Walther MM, Linehan WM, Sukhatme VP, Weinstein MH, Rangnekar VM. Cook J, et al. Among authors: rangnekar vm. Oncogene. 1999 Feb 4;18(5):1205-8. doi: 10.1038/sj.onc.1202416. Oncogene. 1999. PMID: 10022126

5

Oncogenic Ras sensitizes cells to apoptosis by Par-4.

Nalca A, Qiu SG, El-Guendy N, Krishnan S, Rangnekar VM. Nalca A, et al. Among authors: rangnekar vm. J Biol Chem. 1999 Oct 15;274(42):29976-83. doi: 10.1074/jbc.274.42.29976. J Biol Chem. 1999. PMID: 10514481 Free article.

6

Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation.

Qiu SG, Krishnan S, el-Guendy N, Rangnekar VM. Qiu SG, et al. Among authors: rangnekar vm. Oncogene. 1999 Nov 25;18(50):7115-23. doi: 10.1038/sj.onc.1203199. Oncogene. 1999. PMID: 10597313

7

Apoptosis by Par-4 in cancer and neurodegenerative diseases.

El-Guendy N, Rangnekar VM. El-Guendy N, et al. Among authors: rangnekar vm. Exp Cell Res. 2003 Feb 1;283(1):51-66. doi: 10.1016/s0014-4827(02)00016-2. Exp Cell Res. 2003. PMID: 12565819 Review.

8

Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.

Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G. Cheema SK, et al. Among authors: rangnekar vm. J Biol Chem. 2003 May 30;278(22):19995-20005. doi: 10.1074/jbc.M205865200. Epub 2003 Mar 17. J Biol Chem. 2003. PMID: 12644474 Free article.

9

Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues.

Boghaert ER, Sells SF, Walid AJ, Malone P, Williams NM, Weinstein MH, Strange R, Rangnekar VM. Boghaert ER, et al. Among authors: rangnekar vm. Cell Growth Differ. 1997 Aug;8(8):881-90. Cell Growth Differ. 1997. PMID: 9269897

10

Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.

Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM. Qiu G, et al. Among authors: rangnekar vm. Oncogene. 1999 Jan 21;18(3):623-31. doi: 10.1038/sj.onc.1202344. Oncogene. 1999. PMID: 9989812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters